CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 157 filers reported holding CARA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $156,610 | -40.6% | 93,220 | 0.0% | 0.00% | – |
| Q2 2023 | $263,813 | +13.4% | 93,220 | +96.7% | 0.00% | – |
| Q1 2023 | $232,734 | -59.9% | 47,400 | -12.3% | 0.00% | – |
| Q4 2022 | $580,615 | +23.0% | 54,061 | +7.2% | 0.00% | – |
| Q3 2022 | $472,000 | +13.7% | 50,420 | +10.9% | 0.00% | – |
| Q2 2022 | $415,000 | -24.7% | 45,456 | +0.3% | 0.00% | – |
| Q1 2022 | $551,000 | 0.0% | 45,330 | +0.2% | 0.00% | – |
| Q4 2021 | $551,000 | -35.1% | 45,222 | -17.7% | 0.00% | – |
| Q3 2021 | $849,000 | +4.2% | 54,920 | -3.8% | 0.00% | – |
| Q2 2021 | $815,000 | -23.4% | 57,090 | +16.5% | 0.00% | – |
| Q1 2021 | $1,064,000 | +43.6% | 49,000 | 0.0% | 0.00% | – |
| Q4 2020 | $741,000 | -5.6% | 49,000 | -20.6% | 0.00% | – |
| Q3 2020 | $785,000 | -27.7% | 61,700 | -2.8% | 0.00% | -100.0% |
| Q2 2020 | $1,086,000 | +80.4% | 63,500 | +39.3% | 0.00% | – |
| Q1 2020 | $602,000 | -18.1% | 45,600 | 0.0% | 0.00% | – |
| Q4 2019 | $735,000 | -7.5% | 45,600 | +4.8% | 0.00% | – |
| Q3 2019 | $795,000 | -15.0% | 43,500 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $935,000 | -61.5% | 43,500 | -64.9% | 0.00% | -50.0% |
| Q1 2019 | $2,431,000 | +44.2% | 123,890 | -4.5% | 0.00% | +100.0% |
| Q4 2018 | $1,686,000 | +61.0% | 129,690 | +196.8% | 0.00% | 0.0% |
| Q3 2018 | $1,047,000 | +15.3% | 43,700 | -7.8% | 0.00% | 0.0% |
| Q2 2018 | $908,000 | +36.5% | 47,400 | -11.7% | 0.00% | – |
| Q1 2018 | $665,000 | +40.9% | 53,700 | +39.1% | 0.00% | – |
| Q4 2017 | $472,000 | -10.6% | 38,600 | 0.0% | 0.00% | – |
| Q3 2017 | $528,000 | -11.1% | 38,600 | 0.0% | 0.00% | – |
| Q2 2017 | $594,000 | +59.2% | 38,600 | +90.1% | 0.00% | – |
| Q1 2017 | $373,000 | +97.4% | 20,300 | 0.0% | 0.00% | – |
| Q4 2016 | $189,000 | +11.2% | 20,300 | 0.0% | 0.00% | – |
| Q3 2016 | $170,000 | +73.5% | 20,300 | 0.0% | 0.00% | – |
| Q2 2016 | $98,000 | -49.0% | 20,300 | +78.1% | 0.00% | – |
| Q4 2015 | $192,000 | +3100.0% | 11,400 | +1800.0% | 0.00% | – |
| Q1 2015 | $6,000 | 0.0% | 600 | 0.0% | 0.00% | – |
| Q4 2014 | $6,000 | +20.0% | 600 | 0.0% | 0.00% | – |
| Q3 2014 | $5,000 | -75.0% | 600 | -50.0% | 0.00% | – |
| Q2 2014 | $20,000 | – | 1,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,204,449 | $10,824 | 1.35% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,233,000 | $6,054,030 | 1.14% |
| Chescapmanager LLC | 1,160,392 | $5,698 | 0.90% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,732,375 | $8,505,961 | 0.22% |
| XTX Topco Ltd | 107,610 | $528,365 | 0.11% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 84,530 | $415,042 | 0.08% |
| PINNACLE ASSOCIATES LTD | 679,413 | $3,335,918 | 0.07% |
| PDT Partners, LLC | 102,010 | $500,869 | 0.07% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,995,370 | $9,797,267 | 0.05% |
| AXQ CAPITAL, LP | 27,760 | $136,302 | 0.05% |